Alejandro
Sousa Escandon
Instituto Valenciano de Oncologia
Valencia, EspañaPublications in collaboration with researchers from Instituto Valenciano de Oncologia (1)
2023
-
Hyperthermic Mitomycin C in Intermediate-risk Non-muscle-invasive Bladder Cancer: Results of the HIVEC-1 Trial
European urology oncology, Vol. 6, Núm. 1, pp. 58-66